Genpharmasec logo

Genpharmasec financials and balance sheet

BSE: 531592Commercial Services & SuppliesSmall Cap

Last close ₹0.99down ₹0.03 (2.94%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹1.02.

52-week range of traded prices to 23 Oct 2026
₹0.75Low, 30 Mar 2026₹1.84High, 27 Oct 2025
Market cap
₹55 Cr3,222nd largest listed
P/E
Earlier quarters restated in the year
P/B
0.8
Dividend yield
Nonein the last 12 months
ROCE
−1.4%
Debt to equity
0.50
Volume, BSE
4,22,891

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Genpharmasec annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹131 Cr, year to Mar 2026A loss in 1 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 28.2% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue131
  2. Materials and goods−126
  3. Employee costs−1.0
  4. Other expenses−1.9
  5. Operating profit2.4
  6. Depreciation−0.3
  7. Other income+4.9
  8. One-off items0.0
  9. Finance costs−0.6
  10. Profit before tax6.4
  11. Tax−1.0
  12. Net profit5.4

What the company owns

  • Plant, investments and other assets₹60 Cr
  • Receivables₹28 Cr
  • Inventory₹13 Cr
  • Cash and bank₹9 Cr

What pays for it: net worth and liabilities

  • Net worth₹71 Cr
  • Owed to suppliers₹30 Cr
  • Other liabilities₹5 Cr
  • Borrowings₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March.Genpharmasec quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 30 JunMar 2021Filed 9 JulMar 2022Filed 8 JunMar 2023Filed 27 MayMar 2024Filed 26 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Revenue from operations000172127263033131
––0162028253033129
Materials and goods bought0–0151927232429126
Employee costs––00001111
Other expenses––00111532
Operating profit before depreciation––011−10002
Operating margin––−23.2%3.9%5.6%−1.9%1.0%0.5%1.3%1.8%
Materials, % of revenue––0.0%92.3%90.1%97.2%91.7%79.7%88.4%96.0%
Employee costs, % of revenue––4.5%0.8%0.9%0.9%2.1%2.5%2.0%0.7%
Other expenses, % of revenue––118.7%3.0%3.4%3.7%5.2%17.3%8.3%1.4%
Depreciation and amortisation0000000000
Operating profit after depreciation––011−10002
Other income0001000135
Finance costs––00000001
One-off items––00000000
Profit before tax0001200036
000000−1011
Net profit0001101025
Other comprehensive income––−1−4−4−5−1−10−1
Total comprehensive income––0−3−3−50−125
Net margin2.7%63.4%61.6%6.1%5.9%−0.8%4.4%0.2%7.5%4.1%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2017 and Mar 2018: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 10 JunMar 2020Filed 30 JunMar 2021Filed 9 JulMar 2022Filed 8 JunMar 2023Filed 27 MayMar 2024Filed 26 JulMar 2025Filed 12 JunMar 2026Filed 21 May
2219211515656771
Share capital2222282828555555
Reserves0−3−7−12−1291116
00003334
067623934
00002335
Total assets22252822207079110
149101305148
816272219402862
Net debt−7−5−11−40−17−2−5
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 9 JulMar 2022Filed 8 JunMar 2023Filed 27 MayMar 2024Filed 26 JulMar 2025Filed 12 JunMar 2026Filed 21 May
−2.1−2.3−3.2−3.03.51.9
−1.8−2.2−3.5−2.33.52.7
−3.0−1.8−3.8−3.03.5−1.3
Receivables−0.21.10.7−3.4−4.7−15.3
Inventories−4.2−2.20.20.80.7−5.3
Payables1.3−0.9−4.91.05.822.1
Other working capital0.20.20.1−1.41.7−2.7
Tax paid−0.40.00.30.00.0−0.8
Interest paid0.00.00.0−0.40.00.0
Capital spending0.00.10.00.00.00.0
Free cash flow−2.1−2.4−3.2−3.03.41.9
−1.40.40.5−28.3−16.5−1.6
4.50.03.147.9−0.40.0
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued4.50.00.027.70.00.0
Net change in cash1.0−1.90.416.6−13.40.3
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 30 JunMar 2021Filed 9 JulMar 2022Filed 8 JunMar 2023Filed 27 MayMar 2024Filed 26 JulMar 2025Filed 12 JunMar 2026Filed 21 May
₹0.00₹0.16₹0.03₹0.05₹0.05−₹0.01₹0.04₹0.00₹0.04₹0.10
As stated that year₹0.03₹1.60₹0.03₹0.05₹0.05−₹0.01₹0.04₹0.00₹0.04₹0.10
₹0.00₹0.16–₹0.02₹0.05−₹0.01₹0.04₹0.00₹0.04₹0.10
––₹1.00₹0.88₹0.75₹0.56₹0.55₹1.17₹1.20₹1.29
Shareholder yield––––−2.0%0.0%0.0%−22.4%0.0%0.0%
Market cap at the year end (₹ crore)1–3232812221528612310543
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Standalone, years to March.Genpharmasec PE ratio and valuation

RatioMar 2018Mar 2019Filed 10 JunMar 2020Filed 30 JunMar 2021Filed 9 JulMar 2022Filed 8 JunMar 2023Filed 27 MayMar 2024Filed 26 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Revenue growth−82.8%357.4%4,299.2%29.1%28.2%−6.6%19.2%8.4%298.5%
Operating profit growth–––84.5%––−37.6%167.6%463.3%
Net profit growth300.0%344.6%336.5%24.7%––−95.9%5,244.9%120.7%
Earnings per share growth5,233.3%−81.3%66.7%0.0%––−100.0%–150.0%
–1.1%5.0%6.3%−1.2%7.3%0.1%3.8%7.9%
––3.9 pts1.4 pts−7.5 pts8.5 pts−7.2 pts3.7 pts4.1 pts
From the net margin––−1.0 pts−0.2 pts−7.2 pts7.8 pts−7.1 pts5.6 pts−1.7 pts
From asset turnover––4.3 pts0.7 pts−0.3 pts0.8 pts−0.1 pts−2.0 pts4.5 pts
From borrowing––0.6 pts0.9 pts0.0 pts−0.1 pts0.0 pts0.0 pts1.3 pts
Return on capital employed–−0.4%3.4%5.7%−3.5%1.3%0.2%0.4%2.9%
Cash conversion–––−169.6%–−286.9%−6,505.6%139.9%35.4%
Interest cover–––––4.20.41.13.6
Debt to equity–0.000.000.000.000.200.050.050.05
Receivable days–00129868210914878
Inventory days––8314613615113310236
Payable days––13313585213610387
Cash conversion cycle, days––−5014013721120714827
Working capital days–95111714415020820514952
Asset turnover–0.020.710.811.101.230.670.441.39
Assets per rupee of net worth–1.001.141.321.371.351.131.141.37
Sales per rupee of plant–535.86341.64441.15263.46255.16299.15361.841,219.59
Capital spending to depreciation–––1.005.670.001.100.050.17
Plant being built, % of plant in use–0.0%–0.0%0.0%0.0%0.0%0.0%0.0%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.8%
Cash from operations against operating profit
79.7%
Measure10 years5 years3 years
Revenue growth, yearly rate–43.9%72.7%
Profit growth, yearly rate–34.1%69.2%
Return on equity, average–3.6%3.9%
Return on capital employed, average–0.3%1.2%
Operating margin, average–0.6%1.2%
Net margin, average15.5%3.1%3.9%
Asset turnover, average–0.970.83
Cash conversion cycle, days, average–146127
Interest cover, average–2.31.7
Debt to equity, average–0.070.05

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−3.22.41.9
Cash from investing−45.4−46.4−1.6
Cash from financing50.547.40.0
Capital spending0.10.10.0
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash27.727.70.0
Borrowings raised––0.8
Borrowings repaid5.75.70.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––52655–
Altman Z-scorePublished threshold 1.1––259.976.167.205.207.20–––
Beneish M-scorePublished threshold −1.78–––––−1.09125.99−0.88––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––18.276.9418.3769.38––
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––−3.54−8.92−0.76–
Receivables growth less revenue growthOur threshold 0 percentage points–––––−42.53−4.8540.23––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––––95.97−9.619.77−12.18––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−3.04−0.730.35−1.385.62––
Assets under construction, years of additionsOur threshold 2 years of additions––––0.000.000.000.00––
Effective tax ratePublished threshold 17.16 per cent−18.1818.7519.6116.2616.63–−299.54–––
Tax charged less tax paid, % of profitOur threshold 10 percentage points––––––−393.32–––
A threshold marked as ours has no published figure; it is the line we read the check against.